UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________________________________________________  FORM 10-K/A-1 ________________________________________________________  [   ]  ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  For the fiscal year ended ________________  [ X ]  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934  For the transition period from March 13, 2013 to December 31, 2013  Commission file number 0-15415  GLOBAL HEALTHCARE REIT, INC. (Exact name of Registrant as specified in its Charter)


|                                                                    |  |                                                 
|------------------------------------------------------------------- |  | ------------------------------------------------
|Utah
(State or other jurisdiction
of incorporation or organization) |  | 87-0340206
I.R.S. Employer
Identification number




|                                                                                           |  |                 
|------------------------------------------------------------------------------------------ |  | ----------------
|3050 Peachtree Road,  Suite 355,  Atlanta Georgia
(Address of principal executive offices) |  | 30305
(Zip Code)

Registrants telephone number: (404) 549-4293  Securities registered pursuant to Section 12(b) of the Act: None  Securities registered pursuant to Section 12(g) of the Act: Common Stock, $.05 par value  Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act [___] Yes  [_X_] No      Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the  Act. [__]  Note  Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Exchange Act from their obligations under those Sections.  Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes [ X ] No [  ]  Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [ X] No [  ]  Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrants knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.   [  ]  Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See definition of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act (check one):


|                              |                        |                             |                                    
|----------------------------- | ---------------------- | --------------------------- | -----------------------------------
|Large accelerated filer [___] | Accelerated filer [__] | Non-accelerated filer [___] | Smaller reporting company  [   X  ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes [  ] No [ X ]  The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold is $17,648,176.  The number of shares outstanding of the registrants common stock, as of April 30, 2014 is 19,867,668.        EXPLANATORY NOTE  This Amendment No. 1 (this Amendment) to the Annual Report on Form 10-K for the period ended December 31, 2013 (the Form 10-K) of Global Healthcare REIT, Inc., is being filed for the purpose of furnishing a dated auditors report covering the consolidated balance sheet of Global Healthcare REIT, Inc. and subsidiaries (the Company) as of December 31, 2013, and the related consolidated statements of operations, changes in equity (deficit), and cash flows for the period from March 13, 2013 (date of inception) through December 31, 2013.  No attempt has been made in this Amendment to modify or update the other disclosures presented in the Form 10-K. This Amendment does not reflect events occurring after the filing of the Form 10-K (i.e., occurring after May 16, 2014) or modify or update those disclosures that may be affected by subsequent events. Such subsequent matters are addressed in subsequent reports filed by the registrant with the SEC. Accordingly, this Amendment should be read in conjunction with the Form 10-K and the registrants other filings with the SEC.          REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM  The Board of Directors of Global Healthcare REIT, Inc.  We have audited the accompanying consolidated balance sheet of Global Healthcare REIT, Inc. and subsidiaries (the Company) as of December 31, 2013, and the related consolidated statements of operations, changes in equity (deficit), and cash flows for the period from March 13, 2013 (date of inception) through December 31, 2013. Our audits also included the consolidated financial statement schedule listed in the index at Item 15(a). These consolidated financial statements and financial statement schedule are the responsibility of the Companys management. Our responsibility is to express an opinion on these consolidated financial statements and financial statement schedule based on our audit.  We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. We were not engaged to perform an audit of the Companys internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Companys internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall consolidated financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.  In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Global Healthcare REIT, Inc. and subsidiaries as of December 31, 2013, and the results of their operations and their cash flows for the period from March 13, 2013 (date of inception) through December 31, 2013, in conformity with U.S. generally accepted accounting principles. Also, in our opinion, the related consolidated financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly in all material respects the information set forth therein.  /s/    Frazier & Deeter, LLC  Atlanta, Georgia May 16, 2014                SIGNATURES  Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this amended annual report to be signed on its behalf by the undersigned, thereunto duly authorized.


|                     |  |                                                             
|-------------------- |  | ------------------------------------------------------------
|                     |  | GLOBAL HEALTHCARE REIT, INC.                                
|Date:  June 11, 2014 |  | By:  __/s/ Christopher Brogdon
Christopher Brogdon
President

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.


|                                                      |                                                         |              
|----------------------------------------------------- | ------------------------------------------------------- | -------------
|SIGNATURE                                             | TITLE                                                   | DATE         
|                                                      |                                                         |              
|_/s/ Christopher Brogdon
Christopher Brogdon          | CEO, President & Director
(Principal Executive Officer) | June 11, 2014
|                                                      |                                                         |              
|__/s/ Steven Bathgate
Steven Bathgate                 | Director                                                | June 11, 2014
|                                                      |                                                         |              
|                                                      |                                                         |              
|/s/ John Joseph Sheehan, Jr.
John Joseph Sheehan, Jr. | Director                                                | June 11, 2014
|                                                      |                                                         |              
|/s/ Clifford L. Neuman
Clifford L. Neuman             | Director                                                | June 11, 2014
|/s/ Philip Scarborough                                |                                                         | June 11, 2014

Philip Scarborough Chief Financial Officer (Principal Financial and Accounting Officer)